Vanda Pharmaceuticals (VNDA) Reports Q1 EPS of $0.06
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.28 -1.86%
Financial Fact:
Research and development: 7.29M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 7.29M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of $0.06. Revenue for the quarter came in at $62.5 thousand, versus $0 reported last year.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
